Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 29, 2012 - Issue 4
Submit an article Journal homepage
182
Views
3
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Bullous Variant of Acral Erythema in a Child After High-Dose Methotrexate

Katja ZilsPediatrics 5 (General Pediatrics, Rheumatology, Gastroenterology, Oncology, Hematology, Immunology), Olgahospital, Klinikum Stuttgart, Stuttgart, GermanyCorrespondence[email protected]
, MD,
Miriam WilhelmPediatrics 5 (General Pediatrics, Rheumatology, Gastroenterology, Oncology, Hematology, Immunology), Olgahospital, Klinikum Stuttgart, Stuttgart, Germany
, MD,
Theresia ReehPediatrics 5 (General Pediatrics, Rheumatology, Gastroenterology, Oncology, Hematology, Immunology), Olgahospital, Klinikum Stuttgart, Stuttgart, Germany
&
Stefan Bielack
, MD
Pages 378-379 | Received 01 Feb 2012, Accepted 08 Feb 2012, Published online: 08 May 2012

REFERENCES

  • Marina N, Bielack S, Whelan J, International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res. 2009;152:339–353.
  • Hellier I, Bessis D, Sotto A, High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol. 1996;132:590–591.
  • Feizy V, Namazi MR, Barikbin B, Ehsani A. Methotrexate-induced acral erythema with bullous reaction. Dermatol Online J. 2003;9:14.
  • Postovsky S, Ben Arush MW. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma. Pediatr Hematol Oncol. 2005;22:167–173.
  • Varela CR, McNamara J, Antaya RJ. Acral erythema with oral methotrexate in a child. Pediatr Dermatol. 2007;24:541–546.
  • Werchniak AE, Chaffee S, Dinulos JG. Methotrexate-induced bullous acral erythema in a child. J Am Acad Dermatol. 2005;52:S93–S95.
  • Tezer H, Kuskonmaz B, Kara A, et al. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema. J Pediatr Hematol Oncol. 2008;30:391–393.
  • Morrell DS, Challgren E, Eapen M, Esterly NB. Bullous acral erythema secondary to high-dose methotrexate. J Pediatr Hematol Oncol. 2002;24:240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.